Innovative 3D Bioprinting to revolutionize the face of the Healthcare Industry to Create USD 5.01 Bn. Market Opportunity
Global 3D Bioprinting Market Size Is Expected To Reach USD 5.01 Billion By 2029, At A CAGR Of 20.07%
As per Maximize Market Research analysis, the 3D Bioprinting market was valued at USD 1.16 billion in 2021 and is projected to reach USD 5.01 billion by 2029, growing at a CAGR of 20.07% during the forecast period.
PUNE, India, Oct. 18, 2022 /PRNewswire/ -- Maximize Market Research, a leading market research company has published an intelligence report titled Global 3D Bioprinting Market 2021. Primary as well as secondary data collection methods were used to collect the data from all the countries covered in the report. Sample selected for primary interviews and sources of secondary research have made this report the most authenticate in the available reports, claimed Mr. Vikas Godage who is an M&A expert in the industry.
Scope of 3D Bioprinting Market Intelligence Report: Get a sample report
The 3D Bioprinting market report provides a detailed analysis of the global 3D Bioprinting market. The report has covered the analysis of all the stakeholders in the industry and has analysed the impact of micro and macro-level policies of each country on the market.
The PORTER and PESTEL by region give detailed market insights in each country. The report will help decision-makers to understand the external and internal forces that affect the market opportunities in the industry and plan their resources accordingly.
The 3D Bioprinting market segmentation analysis and the market size forecast in the report will help investors in understanding the market dynamics and the structure of the 3D Bioprinting market. The report acts as a buyer's guide by clearly outlining the competitive analysis of the major 3D Bioprinter key players' businesses by financial position, by price, product, positioning and the growth strategies.
3D Bioprinting Market Overview:
Traditional tissue engineering techniques comprises of scaffolds, growth factors and cells have limited success in the fabrication of the complex 3D shapes leading to the non-feasibility for the clinical applications. In this regard, 3D Bioprinting, an expanded application of additive manufacturing, is currently being investigated for tissue engineering and regenerative medicine because it uses a top-down approach to build complex tissues layer by layer, producing precise geometries due to the controlled nature of matter deposition with the aid of anatomically accurate 3D models of the tissue created by computer graphics.
3D Bioprinting of living human tissues and organs is expected to increase market value from USD 1.16 Billion in 2021 to USD 5.01 Billion in 2029. Depending on how the final product will be used, the 3D bioprinting market is divided into research and clinical segments. One of the clinical applications that is now possible is the printing of skin, bone, cartilage, and blood vessels. For instance, the use of 3D bioprinting for skin regeneration and wound healing was first reported in 2009, and by 2019 and 2020, there were roughly 19 and 70 published studies respectively on the 3D Bioprint subject.
3D Bioprinting Market Dynamics:
The standard drug development process normally requires 10 to 15 years to produce treatments that are both safe and efficient. In order to speed up drug discovery, new sophisticated technologies like 3D bioprinting are practiced for modification of the drug discovery pipeline. This drug development process is currently entering clinical trials with a 10% success rate. The 3D bioprinting of human tissues has helped in serving as a prospective model that depicts human physiology to deliver more accurate findings, according to study done by numerous scientists from the Nano engineering and Bioengineering Departments.
Several companies are focusing on improving current 3D Bioprinters developments to increase the resolution of the detailed tissue. In addition, the increasing number of waiting list recipient's for organ transplantation boosting the 3-D Bioprinters demand across the world. For Instance, The start-up, based in Chicago A miniature human heart that helps to replicate the characteristics of a healthy human heart was successfully manufactured by BIOLIFE4D. The market for 3D Bioprinters is now being used more frequently because of variety of Bioink innovations. There is a surge in demand for 3D Bioprinters as a result of the development of Bioinks made from the patients' own cells and the capability to create 3D Bioprints precisely in the same dimensions estimated from the patients' MRI scans.
3D Bioprinting Market Segment Analysis:
1. Global 3D Bioprinting Market, by Technology Insights
- Magnetic 3D
- Laser-Assisted
- Inkjet 3D
- Microextrisions
2. Global 3D Bioprinting Market, by Deployment Mode
- Hydrogels
- Extracellular Matrices
- Living cells
- Other Biomaterials
3. Global 3D Bioprinting Market, by Application Area
- Medical
- Tissue and organ generation
- Medical pills
- Prosthetics and implants
- Others
- Dental
- Biosensors
- Consumer/Personal Product Testing
- Bioinks
- Food and Animal Product
- Others
3D Bioprinting Market Regional Analysis:
In 2021, Asia Pacific held a revenue share of 23.7% in the 3D Bioprinting market and is expected to maintain its dominance over the coming years. Due to the growing number of COVID-19 cases and increased government R&D spending, Japan and China accounted for the greatest revenue share in the area.
The North American market had a revenue share of 31.6%, and it is anticipated that it will continue to dominate for the forecasted period. In addition, it is expected that the market would rise due to the growing adoption of IT in the healthcare sector. As this technology has been recognised for use in drug testing and organ donation, there is an increasing demand for 3D Bioprinting.
List of 3D Bioprinting Market Key Players:
- EnvisionTEC, Inc.
- Organovo Holdings, Inc.
- Inventia Life Science PTY LTD
- Poietis
- Vivax Bio, LLC
- Allevi
- Cyfuse Biomedical K.K.
- 3D Bioprinting Solutions
- Cellink Global
- Regemat 3D S.L.
- Bico group ab,
- Collplant Biotechnologies Ltd.
- Regenhu
- Aspect Biosystems Ltd.
- Advanced Solutions Life Sciences, LLC
- Rokit Healthcare, inc.
- Pandorum Technologies pvt. ltd.
- Foldink Life Science Technologies
- Revotek co., ltd.
- Precise Bio
Key Questions answered in the 3D Bioprinting Market Report are:
- Which product segment held the largest share in the 3D Bioprinting market in 2021?
- Competitive scenario of the 3D Bioprinting market?
- Which are the key factors aiding the 3D Bioprinting market growth?
- Which region holds the maximum share in the 3D Bioprinting market?
- What will be the CAGR of the 3D Bioprinting market during the forecast period?
- Which application segment emerged as the leading segment in the 3D Bioprinting market?
- Which are the prominent players in the 3D Bioprinting market?
- What key trends are likely to emerge in the 3D Bioprinting market in the coming years?
- What will be the 3D Bioprinting market size by 2027?
- Which company held the largest share in the 3D Bioprinting market?
To Access Full Copy of Report: Click Here
Maximize Market Research is leading healthcare and biotechnology research firm, has also published report on:
Biomaterial Market: Industry analysis and Forecast to 2029
Tissue Diagnostics Market – Global Industry Analysis and Forecast to 2029
About Maximize Market Research:
Maximize Market Research provides syndicate as well as custom made business and market B2B and B2C research on 6,500 high growth emerging technologies and opportunities as well as threats to the companies across the Chemical, Healthcare, Pharmaceuticals, Electronics and Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Maximize Market Research is positioned to estimate and forecast the market size with competitive landscape of the industries. Additional information is available at https://www.maximizemarketresearch.com/.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
[email protected]
+91 96071 95908, +91 96073 65656
Logo: https://mma.prnewswire.com/media/1923893/MMR_Logo.jpg
Share this article